Reanalysis for PK Reason: Gone with the Wind [Bioanalytics]

posted by dshah  – India, 2020-07-17 08:40 (1771 d 05:51 ago) – Posting: # 21729
Views: 8,529

Greetings team!

I believe that Helmut is correct and without a predefined SOP for repeat analysis, repeat would not be acceptable!

If we are focusing on root cause, I believe that for pre-dose concentration even in period-I would not cause a significant issue to final BE out come as it may only impact AUC and it would not be significant. :-D If the value is MT 5% of Cmax, the subject would by default not considered for statistical evaluation :-). And for Root cause- most of CRO are not able to identify and thus there would not be a CAPA. :confused:


Thanks,
Dshah


Edit: Full quote removed. Please delete everything from the text of the original poster which is not necessary in understanding your answer; see also this post #5! [Ohlbe]

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,679 registered users;
50 visitors (0 registered, 50 guests [including 18 identified bots]).
Forum time: 14:31 CEST (Europe/Vienna)

Pharmacokinetics may be simply defined as
what the body does to the drug,
as opposed to pharmacodynamics, which may be defined as
what the drug does to the body.    Leslie Z. Benet

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5